HALAVEN is the first and only chemotherapy proven to help some women live longer when used alone after 2 prior chemotherapies for mBC.
In a clinical study of more than 750 women, HALAVEN was compared with other chemotherapies or hormone therapies commonly used to treat mBC. Although some women lived longer and some women did not live as long, women who were treated with HALAVEN lived, on average, 25% longer than those who received another chemotherapy or hormone treatment (13.2 months vs 10.6 months, respectively).
In this study, 8 out of 10 women had breast cancer that had spread to other sites including their liver and/or lungs.
WOMEN WHO RECEIVED HALAVEN LIVED, ON AVERAGE, 25% LONGER THAN WOMEN WHO RECEIVED OTHER CHEMOTHERAPY OR HORMONE THERAPY (13.2 months vs 10.6 months).
HALAVEN was studied in women with all types of tumor receptors. This means that their ER/PR hormone receptors (estrogen/progesterone receptors) were either positive or negative and their HER2/neu receptors (human epidermal growth factor receptor 2) were either positive or negative.
HALAVEN is a prescription medicine used to treat adults with breast cancer that has spread to other parts of the body, and who have already received other types of anticancer medicines after the cancer has spread.
HALAVEN can cause serious side effects, including
Before you receive HALAVEN, tell your health care provider about all of your medical conditions, including if you
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of HALAVEN?
HALAVEN can cause changes in your heartbeat (called QT prolongation). This can cause irregular heartbeats. Your health care provider may do heart monitoring (electrocardiogram or ECG) or blood tests during your treatment with HALAVEN to check for heart problems.
The most common side effects of HALAVEN in adults with breast cancer include low white blood cell count (neutropenia), low red blood cell count (anemia), weakness or tiredness, hair loss (alopecia), nausea, and constipation.
Your health care provider will do blood tests before and during treatment while you are taking HALAVEN.
For more information about HALAVEN, please see full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.